Columnists
Tipsheet
Cartoons
Podcasts
Newsletters
Sections
Podcasts
Townhall TV
Election
Capitol Voices
Entertainment
Radio News
Live Blog
Topics
Sites
Hot Air
PJ Media
Bearing Arms
Twitchy
RedState
JOIN VIP
LOGIN
MY ACCOUNT
Account Settings
Newsletter Subscriptions
Log Out
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Moderna Inc
(NQ:
MRNA
)
60.20
-0.87 (-1.42%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Oct 4, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Moderna Inc
< Previous
1
2
3
4
5
6
7
8
9
...
99
100
Next >
Coinbase, Nike And Moderna Are Among Top 11 Large Cap Losers Last Week (Sept 30-Oct 4): Are The Others In Your Portfolio?
Today 13:13 EDT
Eleven large-cap stocks were worst performers last week. Decline in Stars performance and sales, regulations and supply issues caused the drop.
Via
Benzinga
As Weight-Loss Drugs Battle, Upstart Viking Therapeutics Threatens Eli Lilly, Novo Nordisk, Pfizer
October 04, 2024
Viking Therapeutics is an upstart in the weight-loss drugs space. But it's catching attention.
Via
Investor's Business Daily
Alnylam's Concedes Its Patent Infringement Case Against Moderna's COVID-19 Vaccine
October 03, 2024
Alnylam Pharmaceuticals has conceded that Moderna's products do not infringe on its patents, as a court ruling determined. Both companies have agreed to dismiss the case without prejudice for possible...
Via
Benzinga
Topics
Intellectual Property
Exposures
COVID-19
Intellectual Property
Is It Time to Buy September's Worst-Performing S&P 500 Stocks?
October 02, 2024
Could rebounds be in store for these beaten-down stocks?
Via
The Motley Fool
Topics
Stocks
Exposures
US Equities
Here's How Much $100 Invested In Moderna 5 Years Ago Would Be Worth Today
September 24, 2024
Via
Benzinga
16 Analysts Have This To Say About Moderna
September 13, 2024
Via
Benzinga
Here's How Much You Would Have Made Owning Moderna Stock In The Last 5 Years
September 13, 2024
Via
Benzinga
The Covid Era Tech Promises To Reinvent Cancer Treatment
October 01, 2024
Pfizer Inc (NYSE: PFE) made a promise to outdo cancer, joining its Covid vaccine-peer, Moderna Inc (NASDAQ: MRNA) in turning to oncology for its next growth story.
Via
Benzinga
Exposures
COVID-19
3 Surprisingly Underrated Stocks to Buy Right Now
September 28, 2024
These stocks might look like bad picks. But appearances can be deceiving.
Via
The Motley Fool
Top 3 Health Care Stocks That May Explode This Month
September 23, 2024
Via
Benzinga
2 Beaten-Down Stocks to Buy and Hold for a Decade
September 23, 2024
These innovative companies have the tools to rebound.
Via
The Motley Fool
Pfizer Advances On Its Cancer Journey
September 20, 2024
On Saturday, Pfizer Inc (NYSE: PFE) presented positive trial data for experimental drug designed for patients suffering from cancer cachexia during the European Society for Medical Oncology 2024...
Via
Benzinga
Down 13% in 1 Day, Is Moderna Stock in Trouble?
September 20, 2024
There's no hope of it recovering to its prior heights anytime soon.
Via
The Motley Fool
Novo Nordisk Just Took a $530 Million Step Onto Moderna's Turf. Here's What It Means for Both Stocks
September 19, 2024
This strategic play will take time to pay off, but it could keep growth going.
Via
The Motley Fool
10 Health Care Stocks With Whale Alerts In Today's Session
September 18, 2024
Via
Benzinga
Jim Cramer Labels Moderna A 'Big Disappointment,' But Suggests Doubling Down On Another Pharma Powerhouse
September 18, 2024
Jim Cramer likes Pfizer and recommends buying more stock. Six Flags is struggling, but Cramer likes First Solar and Equity Residential. Moderna has been disappointing, but Cramer likes Vertiv and...
Via
Benzinga
Prediction: These Could Be the Best-Performing Biotech Stocks Through 2030
September 18, 2024
These biotech stocks have what it takes to be the biggest winners through the rest of the decade and beyond.
Via
The Motley Fool
S&P 500 Briefly Hits Record High Just Ahead Of Fed Rate Cut, Extends 7-Day Winning Streak: Tuesday's Top 5 Gainers
September 17, 2024
S&P 500 hits new record highs amidst expectations for Fed interest rate decision. Small-cap stocks outperform, while uncertainty remains.
Via
Benzinga
Topics
Economy
Stocks
Exposures
Interest Rates
US Equities
Momentum Investing Gives You An Edge, Until It Doesn’t
September 17, 2024
Since 2020, momentum investing has generated significantly better returns than other strategies. Such is not surprising, given the massive amounts of stimulus injected into the financial system.
Via
Talk Markets
Small Caps, Bitcoin Rally As Traders Await Fed Rate Cut; Treasury Yields, US Dollar Tick Up On Strong Retail Sales: What's Driving Markets Tuesday?
September 17, 2024
Wall Street experienced a slightly positive session Tuesday, supported by investor optimism as the Federal Open Market Committee (FOMC) kicked off its two-day meeting, expected to deliver the first...
Via
Benzinga
Topics
Economy
Exposures
Interest Rates
What's Going On With Moderna Shares Tuesday?
September 17, 2024
Moderna shares are moving higher on Tuesday after the company announced that Health Canada approved its updated COVID-19 vaccine.
Via
Benzinga
Exposures
COVID-19
DeSantis Administration Cautions Against Pfizer, Moderna mRNA Covid Vaccines for Vulnerable Individuals, Cites Concerns Related To Rare Heart Conditions
September 16, 2024
Florida advises against mRNA Covid vaccines for vulnerable residents, citing safety concerns. Gov. DeSantis' administration urges healthcare providers to prioritize alternative vaccines for seniors and...
Via
Benzinga
Exposures
COVID-19
Moderna, Tyson Foods And Adobe Are Among Top 10 Large Cap Stock Losers Last Week (Sep 8-Sep 14): Are The Others In Your Portfolio?
September 15, 2024
10 worst performing large-cap stocks last week: RTO, ALLY, MRNA, HUM, TSN, BEKE, ADBE, RYAAY, JPM, DVN. Consider impact on your portfolio.
Via
Benzinga
Down More Than 50%, Is It Time to Buy Moderna Stock as the Biotech Charts a New Post-COVID Path?
September 15, 2024
This highflier has fallen on hard times recently.
Via
The Motley Fool
Wall Street's Top 10 Stock Calls This Week - Saturday, Sept. 14
September 14, 2024
What has Wall Street been buzzing about this week? Here are the top 5 buy calls and the top 5 sell calls made by Wall Street's best analysts during the trading week of Sept. 9-13, 2024.
Via
Talk Markets
Investing in Biotech or Pharma Stocks? Pay Attention to These 3 Things and You'll Win More
September 14, 2024
Financial factors aren't the only things that are worth paying attention to.
Via
The Motley Fool
After Moderna's Shocking News, Is the Stock a Buy or a Sell?
September 14, 2024
Moderna held its annual R&D day this week.
Via
The Motley Fool
Moderna Faces Analyst Downgrades Amid Revised R&D Restructured Strategy and Delayed Profitability Target
September 13, 2024
Moderna announces plans to reduce R&D spending by $1.1 billion by 2027, focusing on ten key products. Analysts highlight near-term challenges, lowered price targets, and a delayed breakeven to 2028,...
Via
Benzinga
Oracle To Rally Around 23%? Here Are 10 Top Analyst Forecasts For Friday
September 13, 2024
Via
Benzinga
Moderna's Pain Continues Amid Flurry Of Downgrades Following 'Tough' R&D Day
September 13, 2024
The company offered a series of updates that shook shares on Thursday. The selloff continued on Friday.
Via
Investor's Business Daily
< Previous
1
2
3
4
5
6
7
8
9
...
99
100
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.